Replies to post #404832 on Amarin Corp Plc (AMRN)

[Birdrockboy]

Be nice if Feurstein and Herper would promote the positive results and stop being deniers.

[Whalatane]

38% RR for low HDL / High TG .
Well since thats me ...mixed D ....HDL usually in the mid 30's and before Vascepa , TG's in the mid 200's ....the dreaded 1 to 7 ratio that concerned my UCSF Cardiologist .
Now if some independent Real World Data without a mineral oil placebo would just confirm that number ...I'd be one happy camper ......and AMRN PPS would be a lot higher .
Kiwi

[Nukemtiltheyglow]

Thanks Captain; Only a matter of time for Vascepa to be accepted worldwide. It took some time for Statins to be accepted. Now look at the size of the Statin marketplace.
Lovastatin first introduced September 1, 1987
https://jamanetwork.com/journals/jamacardiology/fullarticle/2583424#:~:text=Trends%20in%20Statin%20Use&text=The%20first%20statin%2C%20lovastatin,ago%20on%20September%201%2C%201987.

Unlike our present Amarin management team, who threw in the towel in the US market. Plus all the other opportunities they passed on. Vascepa is a prime example of a great medication before it's time. Will Vascepa become a Household name? Perhaps under the right leadership.